Literature DB >> 24530532

Role of neuregulin-1β in dexamethasone-enhanced surfactant synthesis in fetal type II cells.

George King1, Garth L Maker2, David Berryman1, Robert D Trengove3, Max H Cake1.   

Abstract

It is well established that glucocorticoids elevate the production of fibroblast-pneumocyte factor (FPF), which induces type II cells to synthesize surfactant phospholipids. FPF, however, has not been identified and it is not clear whether it is a single factor or a complex mixture of factors. In this study it has been shown that, when lung fibroblasts are exposed to dexamethasone, the concentration of neuregulin-1β (NRG1β) in conditioned medium is elevated 2-fold (P<0.05), even though NRG1β gene expression is unaffected. This, together with the finding that exposure of type II cells to NRG1β directly stimulates by 3-fold the rate of phospholipid synthesis (P<0.05), suggests that NRG1β is a component of FPF that promotes lung development.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibroblast-conditioned media; Neuregulin-1β; Surfactant phospholipid; Type II pneumocyte

Mesh:

Substances:

Year:  2014        PMID: 24530532     DOI: 10.1016/j.febslet.2014.01.057

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Glucocorticoid regulation of lung development: lessons learned from conditional GR knockout mice.

Authors:  A Daniel Bird; Annie R A McDougall; Bennet Seow; Stuart B Hooper; Timothy J Cole
Journal:  Mol Endocrinol       Date:  2014-12-23

Review 2.  Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?

Authors:  Tomoshige Kino; Irina Burd; James H Segars
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 3.  What is the identity of fibroblast-pneumocyte factor?

Authors:  George King; Megan E Smith; Max H Cake; Heber C Nielsen
Journal:  Pediatr Res       Date:  2016-08-08       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.